vs
Esperion Therapeutics, Inc.（ESPR）与GORMAN RUPP CO（GRC）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是GORMAN RUPP CO的1.0倍（$168.4M vs $166.6M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 2.4%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 2.3%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
戈尔曼-拉普是一家总部位于俄亥俄州曼斯菲尔德的泵类制造商，产品面向市政供水、污水处理、工业、建筑、石油、消防及原始设备制造等多个领域提供配套水泵，公司在纽约证券交易所上市，现任首席执行官为斯科特·金。
ESPR vs GRC — 直观对比
营收规模更大
ESPR
是对方的1.0倍
$166.6M
营收增速更快
ESPR
高出141.3%
2.4%
两年增速更快
ESPR
近两年复合增速
2.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $166.6M |
| 净利润 | — | $13.7M |
| 毛利率 | — | 31.4% |
| 营业利润率 | 50.6% | 14.9% |
| 净利率 | — | 8.3% |
| 营收同比 | 143.7% | 2.4% |
| 净利润同比 | — | 25.2% |
| 每股收益（稀释后） | $0.32 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRGRC
| Q4 25 | $168.4M | $166.6M | ||
| Q3 25 | $87.3M | $172.8M | ||
| Q2 25 | $82.4M | $179.0M | ||
| Q1 25 | $65.0M | $163.9M | ||
| Q4 24 | $69.1M | $162.7M | ||
| Q3 24 | $51.6M | $168.2M | ||
| Q2 24 | $73.8M | $169.5M | ||
| Q1 24 | $137.7M | $159.3M |
净利润ESPRGRC
| Q4 25 | — | $13.7M | ||
| Q3 25 | $-31.3M | $11.3M | ||
| Q2 25 | $-12.7M | $15.8M | ||
| Q1 25 | $-40.5M | $12.1M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | $-29.5M | $12.9M | ||
| Q2 24 | $-61.9M | $8.3M | ||
| Q1 24 | $61.0M | $7.9M |
毛利率ESPRGRC
| Q4 25 | — | 31.4% | ||
| Q3 25 | — | 29.2% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 30.7% | ||
| Q4 24 | — | 30.2% | ||
| Q3 24 | — | 31.3% | ||
| Q2 24 | — | 31.9% | ||
| Q1 24 | — | 30.4% |
营业利润率ESPRGRC
| Q4 25 | 50.6% | 14.9% | ||
| Q3 25 | -11.4% | 12.4% | ||
| Q2 25 | 8.6% | 15.0% | ||
| Q1 25 | -34.0% | 13.5% | ||
| Q4 24 | -6.4% | 13.0% | ||
| Q3 24 | -31.0% | 14.2% | ||
| Q2 24 | 3.5% | 15.4% | ||
| Q1 24 | 52.5% | 12.8% |
净利率ESPRGRC
| Q4 25 | — | 8.3% | ||
| Q3 25 | -35.9% | 6.6% | ||
| Q2 25 | -15.4% | 8.8% | ||
| Q1 25 | -62.2% | 7.4% | ||
| Q4 24 | — | 6.7% | ||
| Q3 24 | -57.2% | 7.7% | ||
| Q2 24 | -83.9% | 4.9% | ||
| Q1 24 | 44.3% | 5.0% |
每股收益（稀释后）ESPRGRC
| Q4 25 | $0.32 | $0.53 | ||
| Q3 25 | $-0.16 | $0.43 | ||
| Q2 25 | $-0.06 | $0.60 | ||
| Q1 25 | $-0.21 | $0.46 | ||
| Q4 24 | $-0.14 | $0.42 | ||
| Q3 24 | $-0.15 | $0.49 | ||
| Q2 24 | $-0.33 | $0.32 | ||
| Q1 24 | $0.34 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $35.1M |
| 总债务越低越好 | — | $307.5M |
| 股东权益账面价值 | $-302.0M | $414.7M |
| 总资产 | $465.9M | $860.1M |
| 负债/权益比越低杠杆越低 | — | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资ESPRGRC
| Q4 25 | $167.9M | $35.1M | ||
| Q3 25 | $92.4M | $42.9M | ||
| Q2 25 | $86.1M | $27.0M | ||
| Q1 25 | $114.6M | $21.8M | ||
| Q4 24 | $144.8M | $24.2M | ||
| Q3 24 | $144.7M | $39.7M | ||
| Q2 24 | $189.3M | $34.2M | ||
| Q1 24 | $226.6M | $27.8M |
总债务ESPRGRC
| Q4 25 | — | $307.5M | ||
| Q3 25 | — | $322.3M | ||
| Q2 25 | — | $337.1M | ||
| Q1 25 | — | $352.2M | ||
| Q4 24 | — | $366.6M | ||
| Q3 24 | — | $381.0M | ||
| Q2 24 | — | $395.4M | ||
| Q1 24 | — | $400.7M |
股东权益ESPRGRC
| Q4 25 | $-302.0M | $414.7M | ||
| Q3 25 | $-451.4M | $405.2M | ||
| Q2 25 | $-433.5M | $397.8M | ||
| Q1 25 | $-426.2M | $382.1M | ||
| Q4 24 | $-388.7M | $373.8M | ||
| Q3 24 | $-370.2M | $367.3M | ||
| Q2 24 | $-344.2M | $358.6M | ||
| Q1 24 | $-294.3M | $353.7M |
总资产ESPRGRC
| Q4 25 | $465.9M | $860.1M | ||
| Q3 25 | $364.0M | $869.9M | ||
| Q2 25 | $347.1M | $861.8M | ||
| Q1 25 | $324.0M | $857.8M | ||
| Q4 24 | $343.8M | $858.5M | ||
| Q3 24 | $314.1M | $883.5M | ||
| Q2 24 | $352.3M | $891.1M | ||
| Q1 24 | $373.1M | $887.4M |
负债/权益比ESPRGRC
| Q4 25 | — | 0.74× | ||
| Q3 25 | — | 0.80× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.92× | ||
| Q4 24 | — | 0.98× | ||
| Q3 24 | — | 1.04× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.13× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $15.0M |
| 自由现金流经营现金流 - 资本支出 | — | $10.2M |
| 自由现金流率自由现金流/营收 | — | 6.1% |
| 资本支出强度资本支出/营收 | 0.0% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 1.09× |
| 过去12个月自由现金流最近4个季度 | — | $88.9M |
8季度趋势，按日历期对齐
经营现金流ESPRGRC
| Q4 25 | $45.2M | $15.0M | ||
| Q3 25 | $-4.3M | $42.3M | ||
| Q2 25 | $-31.4M | $27.8M | ||
| Q1 25 | $-22.6M | $21.1M | ||
| Q4 24 | $-35.0M | $9.3M | ||
| Q3 24 | $-35.3M | $27.2M | ||
| Q2 24 | $-7.2M | $22.7M | ||
| Q1 24 | $53.8M | $10.7M |
自由现金流ESPRGRC
| Q4 25 | — | $10.2M | ||
| Q3 25 | — | $35.8M | ||
| Q2 25 | — | $24.8M | ||
| Q1 25 | — | $18.1M | ||
| Q4 24 | — | $5.2M | ||
| Q3 24 | $-35.5M | $24.0M | ||
| Q2 24 | $-7.3M | $19.4M | ||
| Q1 24 | $53.8M | $6.8M |
自由现金流率ESPRGRC
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 11.0% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | -68.7% | 14.3% | ||
| Q2 24 | -9.9% | 11.5% | ||
| Q1 24 | 39.0% | 4.3% |
资本支出强度ESPRGRC
| Q4 25 | 0.0% | 2.9% | ||
| Q3 25 | 0.0% | 3.8% | ||
| Q2 25 | 0.0% | 1.7% | ||
| Q1 25 | 0.0% | 1.8% | ||
| Q4 24 | 0.0% | 2.5% | ||
| Q3 24 | 0.3% | 1.9% | ||
| Q2 24 | 0.1% | 1.9% | ||
| Q1 24 | 0.1% | 2.5% |
现金转化率ESPRGRC
| Q4 25 | — | 1.09× | ||
| Q3 25 | — | 3.73× | ||
| Q2 25 | — | 1.76× | ||
| Q1 25 | — | 1.74× | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | — | 2.10× | ||
| Q2 24 | — | 2.72× | ||
| Q1 24 | 0.88× | 1.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
GRC
| Industrial | $34.7M | 21% |
| Fire Market | $31.4M | 19% |
| Municipal | $25.3M | 15% |
| Agriculture | $22.5M | 14% |
| Repair Parts | $18.9M | 11% |
| Construction | $17.3M | 10% |
| Original Equipment Manufacturer | $10.8M | 7% |
| Petroleum | $5.6M | 3% |
